GlassScriptPhysician profile
Fausto Andrade Rodriguez
NPI 1942501739
$40,409.64
in general payments reported to CMS, 2019-2025
14 companies · $27K in 2025
The $27K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,231 · 2020: $111 · 2021: $149 · 2022: $508 · 2023: $1,820 · 2024: $3,429 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Food and Beverage: $3,984 · Travel and Lodging: $3,964 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $15,940.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Food and Beverage | $3,984.36 |
| Travel and Lodging | $3,964.04 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,781.74 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $4,319.25 | 2019-2021 | |
| Medical Device Business Services, INC. | $407.22 | 2021-2025 | Vistaseal |
| Hologic Sales and Service, LLC | $343.99 | 2022-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Ethicon US, LLC | $340.36 | 2022-2023 | Monocryl, Harmonic, Evarrest |
| Astellas Pharma US INC | $49.14 | 2024-2025 | Veozah |
| Momentis Surgical INC. | $30.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.77 | 2023 | Lynparza |
| Exeltis, USA INC. | $20.97 | 2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $19.97 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.53 | 2025 | |
| Solventum Corporation | $18.73 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Allergan, INC. | $18.24 | 2019 | |
| Merck Sharp & Dohme LLC | $16.73 | 2023 | Keytruda, Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fausto Andrade Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.